Table 1 Baseline characteristics of the patients.
| Atorvastatin | Placebo group 3 (n = 15) | |||
|---|---|---|---|---|
| Group 1 NPDR (n = 15) | Group 2 PDR (n = 15) | NPDR (n = 8) | PDR (n = 7) | |
| Age (years) | 56.4 (7.1) | 60.8 (7.7) | 57.5 (8.0) | 58.6 (8.7) |
| Sex (M/F; n) | 8/7 | 10/5 | 3/5 | 4/3 |
| BMI (kg/m2) | 26.9 (3.1) | 27.5 (3.4) | 27.2 (4.0) | 27.4 (3.9) |
| Heart rate (beats/min) | 73.7 (8.0) | 75.0 (8.1) | 74.1 (8.6) | 74.8 (8.9) |
| Weight (kg) | 69.1 (11.4) | 76.0 (14.3) | 75.0 (15.4) | 75.3 (15.0) |
| Duration of diabetes (years) | 9.4 (3.1) | 16.7 (3.4) | 12.9 (3.8) | 15.0 (4.3) |
| HbA1C (%) | 7.6 (1.5) | 8.2 (1.6) | 7.7 (1.7) | 8.0 (1.7) |
| Fasting plasma glucose (mg/dl) | 145.2 (18.4) | 160.5 (20.6) | 158.4 (25.3) | 159.7 (24.4) |
| Blood pressure(mm Hg) | ||||
| Systolic | 115.4 (10.7) | 121.1 (11.2) | 117.8 (9.8) | 119.2 (10.2) |
| Diastolic | 78.2 (7.6) | 80.4 (8.1) | 79.4 (7.4) | 81.6 (8.5) |
| Ocular perfusion pressure (mm Hg) | 46.6 (3.1) | 48.7 (4.0) | 47.2 (3.4) | 48.0 (3.7) |
BMI, body mass index; F, female; HbA1C, glycated haemoglobin; M, male; NPDR, non‐proliferative diabetic retinopathy; PDR, proliferative diabetic retinopathy.
Values are mean (SD) unless otherwise specified.